Results 161 to 170 of about 12,132,339 (300)

Pathologic Th1-Treg Cells Exacerbate Acute Lung Injury and Lethality in Sepsis. [PDF]

Cells
Murao T, Murao A, Aziz M, Wang P.
europepmc   +1 more source

TREG cell therapy [PDF]

Nature Reviews Rheumatology, 2010
openaire   +1 more source

Targeting PLD3 Reverses the Immunosuppressive Niche by Reprogramming Tumor‐Associated Macrophages and Potentiates Antitumor Immunity

Advanced Science, EarlyView.
PLD3 activates the lysosomal‐AKT‐NF‐κB axis to drive cellular senescence in macrophages, establishing an immunosuppressive TME by limiting the infiltration of cytotoxic T, NK, and NKT cells, which confers resistance to anti‐PD‐1 therapy. Abrine inhibits PLD3 expression, restoring antitumor immunity and synergizing with anti‐PD‐1 treatment.
Xingtu Qin, Qiong Li, Xuemei Xu, Yuhan Wu, Yin Zhu, Jieqiong Wu, Yuan Fang, Qiubei Chen, Shuyang Wang, Jiang Yu, Yaping Ye, Hongli Jiao   +11 more
wiley   +1 more source

Analysis of the predictive value of Th17/Treg cells and cytokines for the risk of infection after kidney transplantation. [PDF]

Front Immunol
Li W, Guo J, Yang H, Wang B.
europepmc   +1 more source

Reprogramming the Immune Landscape of Inflammatory Breast Cancer

Advanced Science, EarlyView.
Inflammatory breast cancer is the most lethal subtype of breast cancer and is characterized by an immunosuppressive tumor microenvironment (TME) driven by a complex network of immune cells and inflammatory cytokines, contributing to its aggressiveness and treatment challenges. Immune checkpoint inhibitors, either alone or in combination, show potential
Verena Martinez‐Rodriguez, Suguru Ogata, Xiaoping Wang, Naoto T. Ueno   +3 more
wiley   +1 more source

Isolation of Pure Stable Human Treg Cells Based on Expression of GPA33. [PDF]

Eur J Immunol
Morgana F, Slot E, Amsen D.
europepmc   +1 more source

Muscular Treg cells [PDF]

Nature Medicine, 2014
openaire   +1 more source

PGK1 Suppresses CD8+ T Cell‐Mediated Antitumor Immunity Through CCL2/CCR2/Tumor‐Associated Macrophages Axis in Hepatocellular Carcinoma

Advanced Science, EarlyView.
PGK1 in tumor cells upregulates CCL2 expression through activation of the AKT/GSK‐3β/β‐catenin signaling axis, thereby promoting the recruitment and M2 polarization of TAMs and ultimately impairing the infiltration and activation of CD8+ T cells within the HCC tumor microenvironment. ABSTRACT Patients with advanced hepatocellular carcinoma (HCC) have a
Xi Liu, Jianpeng Liu, Zhihao Zhang, Xizhi Yu, Junjie Qian, Limin Ding, Qinchuan Wu, Zhe Yang, Xing‐Yu Luo, Xinjiang Ding, Rong Su, Xiaobo Yu, Yiting Qiao, Shengyong Yin, Haiyang Xie, Lin Zhou, Yuanxing Liu, Shusen Zheng   +17 more
wiley   +1 more source

Role of Treg cells in diabetes mellitus and association with traditional Chinese medicine: a literature review. [PDF]

Front Immunol
Liu W, Liu R, Wu Z, Zhang Y.
europepmc   +1 more source

mTOR in Treg cells [PDF]

Nature Immunology, 2013
openaire   +1 more source